REG - Imaging Biometrics - Director/PDMR Dealing
Imaging Biometrics Limited
("IB" or the "Company")
PDMR dealing
Imaging Biometrics Limited, a leader in quantitative imaging solutions and novel therapies for CNS malignancies, announces that it has been notified of the following transactions in ordinary shares in the Company undertaken by directors/persons discharging managerial responsibility (PDMR).
The notification below is made in accordance with Article 19(3) of the Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Michael Schmainda | |||
2 | Reason for the notification | ||||
a) | Position/status | Non-Executive Director | |||
b) | Initial notification /Amendment | Initial notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | ||||
a) | Name | Imaging Biometrics, Ltd | |||
b) | LEI | 213800SPW48XRJS2QH57 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each in Imaging Biometrics, Ltd | |||
Identification code | JE00BD4H0R42 | ||||
b) | Nature of the transaction | Purchase of shares | |||
c) | Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0.7 pence | 200,000 Ordinary Shares | ||||
d) | Aggregated information | ||||
- Aggregated volume | 200,000 | ||||
- Price | £1400 | ||||
e) | Date of the transaction | 09/07/2025 | |||
f) | Place of the transaction | London Stock Exchange (XLON) | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHEAKXNEFASEFA
